Medtronic

ill Would Allow Patients Hurt by Faulty Medical Devices To Hold Manufacturers Accountable

March 5, 2009 -- WASHINGTON, D.C. - Congress should quickly pass legislation introduced today that would restore the rights of patients injured by defective or poorly labeled medical devices to hold manufacturers accountable in court, Public Citizen said today.

The Medical Device Safety Act is sponsored by Sen. Edward Kennedy (D-Mass.) and Reps. Henry Waxman (D-Calif.) and Frank Pallone (D-N.J.). Public Citizen and nine other public interest groups sent letters to Kennedy, Waxman and Pallone urging prompt action on the bills.    » read more »

Ongoing Process Improvement Study Underscores Importance of Optimal Medical Care, Including Treatment with Life-Saving Medical and Device Therapy

MINNEAPOLIS – Aug. 28, 2007– Medtronic, Inc., (NYSE: MDT), today announced that it will participate in the Thomas Weisel Partners Healthcare Conference on Wednesday, September 5, 2007 in Boston.

William Hawkins, president and chief executive officer of Medtronic, will deliver the keynote address to attendees of the Thomas Weisel conference at 12:40 p.m. EDT, 11:40 a.m. CDT. Live audio webcast of the presentation will be available to all interested parties at Medtronic’s Investor Relations website at http://investorrelations.medtronic.com/index.cfm.

About Medtronic    » read more »

MINNEAPOLIS – Aug. 23, 2007 – The board of directors of Medtronic, Inc. (NYSE: MDT), today approved a cash dividend of $0.125 per share of the company’s common stock. Medtronic has paid a dividend since the beginning of fiscal 1978 and has increased its dividend each year.

The dividend is payable on October 26, 2007, to shareholders of record at the close of business on October 5, 2007.    » read more »

Michael F. DeMane Elected COO

MINNEAPOLIS, Aug. 23, 2007 – The board of directors of Medtronic, Inc. (NYSE: MDT), today elected William A. Hawkins to the position of president and chief executive officer, and Michael F. DeMane to the position of chief operating officer. Arthur D. Collins, Jr., remains as chairman of the board.

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world.    » read more »

Alliance Will Also Educate People about the Importance of Insulin Pump Therapy and Proactive Diabetes Management

MINNEAPOLIS – August 21, 2007 – Medtronic, Inc. (NYSE:MDT) announced it has been informed by the U.S. Food and Drug Administration (FDA) that an Advisory Panel will review the Premarket Approval (PMA) application for the Endeavor® Drug Eluting Coronary Stent in October. The FDA will announce the date and the complete agenda four to six weeks prior to the meeting in accordance with their normal communications regarding public panel meetings.    » read more »

New Blood Glucose Meter to Provide Advanced Therapy Options for People with Diabetes Beginning in Canada and Europe